• Trial(s) for General Surgery

    Study Objective Contact
    NSABP Protocol B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy And Radiation Therapy Alone For Women With HER2-Positive Ductal Carcinoma In Situ Resected By Lumpectomy [LCID Study Number: 2008-098] This study is being done to compare the effects, good and/or bad, of adding the drug trastuzumab (also called Herceptin®) to breast radiation therapy. Radiation therapy is the standard treatment for patients with DCIS. Principal Investigator(s):
    Stephen E. Karp, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Kori D. Hesse.
  • Make an Appointment

    (781) 744-3982